Hi, it’s Kanoko in Tokyo. The list of new drugs approved in the US and Europe but unavailable in Japan has grown in recent years, and the government has plans to change that. But first…
Japan is the world’s third-biggest pharmaceutical market after the US and China, and home to giants like Takeda and Eisai. And yet, the number of medications greenlit in America and Europe — but not available to patients here — has surged.
